These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4811984)

  • 1. Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.
    Lapey A; Kattwinkel J; Di Sant'Agnese PA; Laster L
    J Pediatr; 1974 Mar; 84(3):328-34. PubMed ID: 4811984
    [No Abstract]   [Full Text] [Related]  

  • 2. Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to cystic fibrosis.
    de Biéville F; Neijens HJ; Fernandes J; van Caillie M; Kerrebijn KF
    Acta Paediatr Scand; 1981 Jan; 70(1):33-7. PubMed ID: 6908433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of L-arginine and sodium bicarbonate in the treatment of malabsorption due to cystic fibrosis.
    Kattwinkel J; Agus SG; Taussig LM; Di Sant'Agnese PA; Laster L
    Pediatrics; 1972 Jul; 50(1):133-7. PubMed ID: 5038088
    [No Abstract]   [Full Text] [Related]  

  • 4. Malabsorption of bile acids in children with cystic fibrosis.
    Weber AM; Roy CC; Morin CL; Lasalle R
    N Engl J Med; 1973 Nov; 289(19):1001-5. PubMed ID: 4742200
    [No Abstract]   [Full Text] [Related]  

  • 5. Nutritional aspects of chronic pancreatitis.
    Taubin HL; Spiro HM
    Am J Clin Nutr; 1973 Mar; 26(3):367-73. PubMed ID: 4571742
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the determination of azotorrhea and steatorrhea in cystic fibrosis of the pancreas].
    Ramos Gracia M; Ros Mar L; Pellicena I
    An Esp Pediatr; 1988 Feb; 28(2):105-7. PubMed ID: 3355025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cimetidine on maldigestion in cystic fibrosis.
    Cox KL; Isenberg JN; Osher AB; Dooley RR
    J Pediatr; 1979 Mar; 94(3):488-92. PubMed ID: 423042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.
    Walters MP; Littlewood JM
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):296-300. PubMed ID: 9740200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic and lipolytic deficiency of the exocrine pancreas.
    Townes PL
    J Pediatr; 1969 Aug; 75(2):221-8. PubMed ID: 5795344
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of four pancreatic extracts in cystic fibrosis.
    Beverley DW; Kelleher J; MacDonald A; Littlewood JM; Robinson T; Walters MP
    Arch Dis Child; 1987 Jun; 62(6):564-8. PubMed ID: 3304172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
    Regele S; Henker J; Münch R; Barbier Y; Stern M
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acid malabsorption in cystic fibrosis.
    Nutr Rev; 1974 Aug; 32(8):232-4. PubMed ID: 4602696
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis.
    Goodchild MC; Sagaró E; Brown GA; Cruchley PM; Jukes HR; Anderson CM
    Br Med J; 1974 Sep; 3(5933):712-4. PubMed ID: 4606368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titrimetric measurements of fecal trypsin and chymotrypsin in cystic fibrosis with pancreatic exocrine insufficiency.
    Dyck WP
    Am J Dig Dis; 1967 Mar; 12(3):310-7. PubMed ID: 6019224
    [No Abstract]   [Full Text] [Related]  

  • 16. Current concepts: pancreatic extracts.
    Littman A; Hanscom DH
    N Engl J Med; 1969 Jul; 281(4):201-4. PubMed ID: 4892805
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis.
    Brady MS; Rickard K; Yu PL; Eigen H
    J Am Diet Assoc; 1992 Jul; 92(7):813-7. PubMed ID: 1624649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice.
    Littlewood JM
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S56-62; discussion S59-62. PubMed ID: 8869184
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis.
    Beker LT; Fink RJ; Shamsa FH; Chaney HR; Kluft J; Evans E; Schidlow DV
    J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):191-7. PubMed ID: 7815242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of misoprostol on fat malabsorption in cystic fibrosis.
    Littlewood JM; Kelleher J
    Arch Dis Child; 1989 Jul; 64(7):1096-7. PubMed ID: 2637701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.